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ABSTRAK 
Pengenalan: Hiperglisemia yang dikesan diperingkat awal semasa kemasukan ke 
wad merupakan penanda risiko morbiditi dan mortaliti bagi pelbagai penyakit kritikal 
akut. Namun tiada sebarang kajian sebelum ini dijalankan untuk mengkaji hiperglisemia 
di peringkat awal di kalangan pesakit sepsis teruk dan kejutan septik yang dirawat di 
jabatan kecemasan.  
Objektif: Untuk mengkaji sama ada hiperglisemia yang dikesan semasa presentasi 
awal pesakit ke jabatan kecemasan mempunyai nilai prognostik di kalangan pesakit 
sepsis teruk dan kejutan septik; dan seterusnya membuat perbandingan dengan lain-lain 
parameter prognostik. 
Kaedah: Kajian ini merupakan kajian retrospektif bagi pesakit sepsis teruk dan 
kejutan septik yang dirawat di Zon Merah, Jabatan Kecemasan, Hospital Universiti 
Sains Malaysia bagi tahun 2008- 2011. Pengumpulan data dilakukan dengan 
mengenalpasti pesakit melalui rekod pendaftaran pesakit. Data demografi, bacaan awal 
glukosa darah kapillari dan lain-lain parameter yang berkaitan dengan morbiditi dan 
mortaliti bagi pesakit sepsis teruk dan kejutan septik diambil dan direkodkan.  
Hasil: Data dikumpulkan dari 495 pesakit dengan sepsis teruk dan kejutan septik. 
Prevalens hiperglisemia stres adalah 14.9%; dan hiperglisemia diperingkat awal secara 
keseluruhan adalah 40.2%. Hiperglisemia awal mempunyai nilai prognostik dalam 
menentukan risiko kematian di kalangan pesakit bukan diabetes (Chi-square 32.7% vs 
59.1%, p-value 0.001). Tidak ada korelasi yang signifikan ditemui antara hiperglisemia 
awal dengan tinggal berpanjangan di hospital. Namun apabila analisis multivariat 
dilakukan hanya markah mMEDs yang tinggi, tahap laktat yang tinggi dan penggunaan 
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ventilator mekanikal mempunyai kaitan untuk menentukan mortaliti dan; untuk tinggal 
berpanjangan di hospital hanya markah mMEDs yang tinggi mempunyai nilai 
prognostik. 
Kesimpulan: Hiperglisemia awal mempunyai nilai prognostik dalam menentukan 
mortaliti bagi pesakit bukan diabetes tetapi tidak di kalangan pesakit diabetes. Tiada 
korelasi boleh dibuat antara hiperglisemia awal dan tinggal berpanjangan di hospital. 
Menentukan tempoh tinggal di hospital merupakan perkara yang kompleks dan tidak 
boleh ditentukan dengan hanya menggunakan faktor tunggal. Jika dibandingkan dengan 
faktor-faktor prognostik lain seperti mMEDS, laktat dan penggunaan ventilator; 
hiperglisemia didapati mempunyai nilai prognostik yang lemah. 
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ABSTRACT  
Introduction: Initial or at-admission hyperglycaemia is a risk marker of morbidity 
and mortality in many acute critical illnesses. There has been no study to evaluate 
hyperglycaemia in severe sepsis and septic shock in the emergency department setting.  
Objectives: To investigate whether hyperglycaemia detected during patient initial 
presentation to emergency department has prognostic value in the outcome of severe 
sepsis and septic shock patients and compare it with other prognostic factors.  
Methods: A retrospective study in patients with severe sepsis and septic shock 
presented to the Red Zone of Emergency Department of Hospital University of Science 
Malaysia during 2008- 2011 was done. Data were collected by tracing patients medical 
records based on the attendance registry. Demographic data, initial capillary blood 
glucose and other factors which may predict the outcomes of severe sepsis and septic 
shock were collected and recorded. 
Results: Data were collected from 495 patients with severe sepsis and septic shock. 
The prevalence of stress hyperglycaemia was 14.9% and the overall initial 
hyperglycaemia was 40.2%.  Initial hyperglycaemia did have significant prognostic 
value in determining mortality in non-diabetic patients (Chi-square 32.7% vs. 59.1%, p-
value 0.001). No significant correlations were found between initial hyperglycaemia 
with prolonged hospital stay. However when multivariate analysis were done only high 
mMEDs score, lactate level and mechanical ventilator were associated with mortality 
and for prolonged length of stay only mMEDs score.  
Conclusion: Initial hyperglycaemia has prognostic value in determining mortality in 
non-diabetic but not in diabetic patients. No correlation can be made between initial 
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hyperglycaemia and prolonged length of stay, as predicting length of stay is a complex 
nature and cannot be determined by single factor. When compared with other prognostic 
factors such as mMEDS score, lactate and ventilator use; hyperglycaemia was found to 
be inferior. 
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1.0 INTRODUCTION  
 In these recent decades, the reported worldwide incidence of sepsis has 
increased dramatically, mostly due to the advancing age of population, an increased 
number of invasive procedure being done and immunosuppressive therapy (Martin et 
al., 2003). It has been estimated that 90.4 cases of severe sepsis per 100,000 population 
in the European Union countries (Davies et al., 2001). While in the United States it is 
estimated 3.0 cases per 1000 population per year or roughly 20 million cases per year 
(Angus et al., 2001). Half of these patients are treated in the Intensive Care Unit (ICU), 
which constitute about 10% of all ICU admissions (Angus et al., 2001).  
 In Malaysia, sepsis is one of the three most common diagnoses leading to ICU 
admissions. A report from the Malaysia Registry of Intensive Care for the year of 2012 
had shown that direct admission to ICU from the emergency department had increased 
from 16.7% in the year of 2008 to 27.9% in 2012 (Tong et al., 2013). With such report, 
we are expecting to see more severe sepsis and septic shock cases presented to our 
emergency department.  
 Not only are we expecting increasing number of severe sepsis and septic shock 
patients in our community, but the fact that the mortality rate for such patients has 
remained high between 30-40% over these past few decades despite the use of 
aggressive antimicrobial agents and advanced life support care surely put more burdens 
and exhaust our healthcare resources (Angus et., 2001, Friedman et al., 1998).  
 Many strategies and measures have been proposed to reduce the mortality rate 
for severe sepsis and septic shock patients, but the most novel of all is the early goal 
directed therapy (EGDT) when applied early in the emergency department rather than 
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initiating the treatment later in the ICU or wards (Rivers et al., 2001). They reported a 
16% absolute risk reduction for in-hospital mortality.  
 Subsequently in 2004, an international group of experts in the diagnosis and 
management of infection and sepsis, representing 11 organizations, published the first 
internationally accepted guidelines that clinician could use to improve the outcomes in 
severe sepsis and septic shock patients. These guidelines represented phase II of the 
Surviving Sepsis Campaign (SSC), a global effort to increase awareness and improve 
outcome in severe sepsis (Dellinger et al., 2004). These guidelines latest updated in 
2012, advocates early recognition, broad-spectrum antibiotics, hemodynamic 
optimization and lung protective strategies (Dellinger et al., 2013).  
 Sepsis has a tendency to rapidly progress to a more severe stage with multi-
organ failure. Late recognition and initiation of treatments contribute to its high 
mortality rate. A Canadian study on the analysis of sepsis hospitalization and factors 
contributing to its mortality, reported that patient whom sepsis was identified in the 
emergency department had lower risk of dying compared with patient whom sepsis was 
not identified in the emergency department (Husak et al., 2010).  
 To identify and diagnose sepsis impose a great challenge for clinician especially 
in a busy and hectic emergency department.  Sepsis manifests itself in vastly variable 
presentations.  It depends on the site of infection, the causative organism, the underlying 
health status of the patient, and the treatment patients may have received prior to 
consultation. From the same  study, it was reported that only 26.4% of patients 
identified as having sepsis prior to admission were identified of having sepsis and had 
diagnosis of sepsis recorded in their emergency department chart (Husak et al., 2010). A 
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thorough clinical history and examination with a high index of suspicious are all needed 
to identify sepsis and thus to treat it accordingly.  
 A reliable risk stratification tools could improve the outcome of sepsis by 
increasing awareness of the seriousness of the disease, deciding the best choice of 
treatment and hasten the transfer of such patients from the emergency department to the 
definite care placement through a more effective communication among health care 
professionals. Various laboratory tests and scoring systems have been developed and 
studied to predict the outcome of sepsis.  
 Example of diagnostic and prognostic biomarkers that available and have been 
studied are, procalcitonin (Harbarth et al., 2001), C-reactive protein (CRP) (Ho and 
Towler, 2009), various interleukins (ILs) (Harbarth et al., 2001), eosinophil count (Ho 
and Towler, 2009), pro-vasopressin (copeptin) (Guignant et al., 2009), interferon- γ 
(IFN-γ) (Wu et al., 2009) and resistin (Koch et al., 2009)  just to name a few. While 
these biomarkers have variable degree of specificity and sensitivity in differentiating 
sepsis from other systemic inflammatory response syndrome (SIRS); and inconsistence 
predictive value in mortality, many of them are not widely available to many emergency 
departments except maybe the CRP.   
 More common and readily available sepsis biomarkers in the emergency 
department such as lactate, base excess and white cell count are also widely studied. 
They too have variable prognostic values in sepsis outcome. Lactate has shown to have 
a moderate predictive value in severe sepsis and septic shock outcome (Arnold et al., 
2009, Nguyen et al., 2004). Base excess alongside lactate has shown to be an acceptable 
prognostic marker in severe sepsis (Silva et al., 2005). As for CRP and leukocyte count, 
studies have revealed that they are not generally accepted as a predictor of mortality 
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even though they have been used as diagnostic markers for sepsis (Hisamuddin and 
Azlan, 2012, Alberti et al., 2005, Lee et al., 2008, Kofoed et al., 2007).  
Shapiro et al in 2003 published a new simple scoring system designed to be 
applied in emergency department in predicting the outcome of sepsis patient. The 
Mortality in Emergency Department Sepsis (MEDS) score uses parameters that are 
readily available in emergency department as to compare with the more complex score 
system like the Acute Physiology and Chronic Health Evaluation II (APACHE II), 
where they are more appropriate to be applied in the ICU (Shapiro et al., 2003). The 
MEDS score in several studies has proved to be adequately predicting mortality in 
sepsis patients (Hermans et al., 2012, Sankoff et al., 2008, Lee et al., 2008).  
 Considering, the workload and fast turnover of patients in many emergency 
departments, a risk stratification tool that is easily available, give instant result, accurate 
and low cost would be the ideal tool. One of the potential risk stratification tools in 
detecting the severity of septic patients that previously may have been overlooked is the 
blood glucose level. Many studies have associated high initial or at-admission blood 
glucose level with adverse outcome in patients in severe trauma (Yendamuri et al., 
2003, Laird et al., 2004), severe head injury (Walia and Sutcliffe, 2002, Oswald and 
Yudkin, 1987), severe burn (Gore et al., 2001), myocardial infarction (Stranders et al., 
2004, Oswald and Yudkin, 1987) and stroke (Capes et al., 2001).   
 Any insult or stress to the human body be it infective or not, will trigger the 
systemic inflammatory response all the same that involves a complex process involving 
the humoral and cellular responses; and activation of the complements and cytokines 
cascades.  Having this in mind, this study wishes to further investigate and explore the 
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relationship between the initial blood sugar level with the outcome of severe sepsis and 
septic shock patients.  
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2.0 LITERATURE REVIEW 
2.1 Body response to insults 
In 1992, the American College of Chest Physicians (ACCP) and the Society of 
Critical Care Medicine (SCCM) introduced the concept and definition for systemic 
inflammatory response syndrome (SIRS), sepsis, severe sepsis, septic shock and 
multiple organs dysfunction syndrome (MODS) (Bone et al., 1992). The idea behind 
defining SIRS was to define a clinical response to a non- specific insult of either 
infectious or non-infectious origins. SIRS is defined as 2 or more of the following 
variables: 
• Fever of more than 38°C or less than 36°C 
• Heart rate of more than 90 beats per minute 
• Respiratory rate of more than 20 breaths per minute or a PaCO2 level of less 
than 32 mm Hg 
• Abnormal white blood cell count (>12,000/µL or <4,000/µL or >10% bands) 
SIRS is nonspecific and can be caused by biologic (microorganisms), physical 
(mechanical insult, radiation), chemical (poisons, acids), metabolic (hypoxia, 
malnutrition), immunologic (autoimmune diseases) or a combination of several insults. 
SIRS is not always related to infection. When SIRS is due to infection it is known as 
sepsis. Severe sepsis is associated with organ dysfunction, hypo-perfusion, or 
hypotension. Sepsis-induced hypotension is defined as "the presence of a systolic blood 
pressure of less than 90 mm Hg or a reduction of more than 40 mm Hg from baseline in 
the absence of other causes of hypotension." Patients meet the criteria for septic shock if 
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they have persistent hypotension and perfusion abnormalities despite adequate fluid 
resuscitation.  
 
 
 
 
 
 
 
 
 
Figure 1: Inter-relation of SIRS with the causes (Bone et al., 1992). 
 
SIRS independent of the aetiology, has the same pathophysiologic properties, 
with minor differences in inciting cascades (Bone et al., 1992). Many consider the 
syndrome as a body self-defence mechanism. Inflammation is system of the defensive 
reactions of the vascularized tissues of the organism to the pathogenic insult of different 
origin. The goal of inflammation is to eliminate the cause, to eliminate destructed tissue 
and, through regeneration or repair, to restore metabolism and function of the organs to 
the state of dynamic balance. The inflammatory cascade is a complex process that 
involves humoral and cellular responses, complement, and cytokine cascades.  
Trauma  
Bacteria  
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The cumulative effect of this inflammatory cascade is an unbalanced state with 
inflammation and coagulation dominating. To counteract the acute inflammatory 
response, the body is equipped to reverse this process via counter inflammatory 
response syndrome (CARS) (Ward et al., 2008). IL-4 and IL-10 are cytokines (CARS 
mediators) responsible for decreasing the production of TNF-a, IL-1, IL-6, and IL-8 
(SIRS mediators). Usually the pro-inflammatory and the anti-inflammatory responses 
are in balance which determines the successful of the healing process. However if there 
is overwhelming production of both SIRS and CARS mediators cause many 
pathological changes in vital organs and system including metabolic changes.  
 
2.2 Hyperglycaemia and the stress response to critical illness 
Stress response is a body mechanism when subjected to external aggression such 
as surgery, burns, sepsis or shock. This response involves hypermetabolism and 
hypercatabolism, one such metabolic change is hyperglycaemia (McCowen et al., 
2001). An elevated blood glucose level in critically ill patients is termed stress 
hyperglycaemia.  It is usually restricted to patient without previous evidence of 
diabetes. However patients with diabetes might also develop stress hyperglycaemia. 
Dungan et al. argue that change in glucose from baseline and not the absolute glucose 
concentration might be of value, irrespective of whether a patient has pre-existing 
diabetes. They propose 2 diagnostic categories of stress hyperglycaemia- hospital 
related hyperglycaemia according to the American Diabetes Association (ADA) 
conferences definition; fasting blood sugar > 6.9 mmol/L or random blood sugar > 11.1 
mmol/L without evidence of previous diabetes and pre-existing diabetes with 
deterioration of pre-illness glycaemic control (Dungan et al., 2009).  
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The exact underlying mechanism of stress hyperglycaemia is not entirely 
understood, but several potential mechanisms have been proposed. These include the 
availability of substrate such as lactate, enhanced gluconeogenesis and decreased of 
glycogenolysis due to excessive counter-regulatory hormones and peripheral insulin 
resistance.  
 
2.2.1 The availability of gluconeogenic substrates  
 Gluconeogenic substrates such as lactate, alanine and glycerol are released in 
abundance during stress (Siegel et al., 1979, Cerra, 1987). For example the lung 
produces a large amount of lactate in patients with acute lung injury; the gastro-
intestinal tract, wounds and injured tissues also produce lactate during stress (Kellum et 
al., 1997, Curtis and Cain, 1992, Willmore, 1986). In sepsis especially in severe sepsis 
and septic shock, cellular anaerobic metabolism and microvascular tissue hypoxia or 
ischemia will lead to increased lactate formation. However in sepsis, increased level of 
lactate is not only due to increased in lactate production but also due to reduced lactate 
clearance and altered energy substrate oxidative pathway metabolic (Levraut et al., 
1998). 
Critical illness enhances alanine and glutamine release from skeletal muscles 
breakdown. This catabolic response is mediated by number of regulators; the main one 
is the glucocorticoids. While the role of cytokines such as TNF-α is thought to be 
through the release of glucocorticoids. Glucocorticoids inhibit protein synthesis (Vary 
and Kimball, 1992) and promote proteolysis (Hasselgren et al., 1989) and subsequently 
amino acids are released into the bloodstream. Acidosis which is usually observed in 
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sepsis is also known to promote protein breakdown, although the mechanism is not 
completely clear (Hasselgren et al., 1987).  
The administration of glucose precursors to hyperglycaemic patients with 
trauma has been shown to stimulate gluconeogenesis and the net hepatic glucose output 
nevertheless remains unaltered (Tappy et al., 1995). This indicates that the auto-
regulation of hepatic glucose production is preserved during critical illnesses, although 
at a higher level of glucose production (Mizock, 2001).  
  
2.2.2 The counter-regulatory hormones  
 The activation of the hypothalamic-pituitary-adrenal (HPA) axis with the release 
of cortisol from the adrenal gland is the hallmark of stress associated with critical illness 
including during sepsis (Marik and Zaloga, 2002). In addition to increased cortisol 
secretion the stress response is also characterized by a marked increase in other counter-
regulatory hormones like glucagon, growth hormone and epinephrine. These hormones 
apart from increasing the production of glucose via glycogenolysis and 
gluconeogenesis, contribute to significant insulin insensitivity through poorly 
understood mechanism likely related to alteration in insulin signal pathway.  Counter-
regulatory hormones also enhance lipolysis and increase level of free fatty acids (FFA) 
in the circulation, which may contribute an additional defect to the normal insulin 
function (Press, 1988). The overall endocrine reaction to stressful events like in sepsis 
shifts the metabolism towards catabolism.  
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2.2.2(i) Cortisol hormone 
 During acute phase of critical illness, the HPA axis response by releasing 
adrenocorticotropin hormone (ACTH) probably secondary to increased in 
corticotrophin-releasing hormone and inflammatory mediators. ACTH and an activated 
rennin-angiotensin system will give rise to a raised secretion of aldosterone and cortisol 
hormones (Van den Berghe, 2000). Apart from that, tumour necrosis factor-α (TNF-α) 
also directly enhances the release of cortisol. Elevated cortisol concentration in the body 
will sharply increases the blood levels of glucose, amino acid and FFA (catabolic 
effects) to ensure the availability of substrates to vital organs such brain and heart 
during stressful event.  These mechanisms seemingly provide the metabolic substrates 
and host defence needed for survival, thus may considered as adaptive and beneficial 
(Van den Berghe, 2000). 
 
2.2.2(ii) Glucagon hormone 
 Glucagon roles is to maintain euglycemia during fasting and acute illness by 
stimulating hepatic glucose output. It increases hepatic glucose output mainly by 
inducing glycogenolysis (Chhibber et al., 2000).  
 
2.2.2(iii) Catecholamines  
 The levels of endogenous catecholamines are normally elevated. In addition, 
exogenous vasopressors are used in hypotension may further increase catecholamines 
blood level in sepsis patients. Epinephrine via β- adrenergic stimulation inhibits insulin-
mediated glucose uptake especially in the skeletal muscles (Deibert and DeFronzo, 
12 
 
1980). The β-adrenergic stimulations disrupt the insulin-signalling pathway by both 
cyclic adenosine monophosphate (cAMP) and cAMP- independent mechanisms 
(Lonnroth and Smith, 1983). It is suggested this inhibitory action occurs at multiple 
sites as the insulin function is disturbed at receptor levels (Linde et al., 1989) and also 
through tyrosine kinase (Eriksson et al., 1992). 
 
2.2.2(iv) Growth hormone 
 During acute phase of critical illness, growth hormone baseline is high and more 
frequent peaks are observed as it is thought to be vital for the biologic effects (Ross et 
al., 1991). Growth hormone executes most of its anabolic effects via insulin-like growth 
factor-1 (IGF-1) and its levels are low in critical illness (Andersen et al., 2004).  
 
2.2.2(v) Counter-regulatory hormones in synergism 
 Shamoon and associates explained the short term effects in normal individuals 
of the combined infusion of hydrocortisone, glucagon and epinephrine. They observed 
increased glucose production and decreased glucose clearance, the effect was more 
prominent when all three hormones were administered together than when they were 
infused separately, suggesting synergistically effect (Shamoon et al., 1981). 
A possible explanation for this synergism is that glucagon increases intracellular 
cAMP, especially in the liver by a non β-receptor mechanism. This could amplify the 
action of epinephrine which acts via β-receptor mechanism. Cortisol acts synergistically 
with epinephrine via cortisol- induced inhibition of catechol-O-methytransferase and 
blockade of catecholamine reuptake. The glucocorticoids also prevent β2-adrenergic 
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receptor down-regulation by increasing both β2-receptor expression and β2-receptor 
gene transcription (Shamoon et al., 1981).  
 
2.2.3 Peripheral insulin resistance 
In normal body function, glucose concentration in the blood is tightly regulated 
even though the rate of glucose uptake and oxidation varies extensively. Three glucose 
transporter isoforms have been indentified to have an essential role in glucose uptake. 
GLUT1 is responsible for the non insulin-mediated glucose uptake (NIMGU) and is 
situated mainly in the erythrocytes and central nervous system. GLUT4 requires insulin 
to be immobilised to the cell membrane and is located mainly in the skeletal muscles.  
Whereas GLUT2 is a bidirectional transporter located in the liver and kidneys.  
Insulin resistance could be due to defective GLUT4 transporter. Pro-
inflammatory cytokines such as interleukin-1 (IL-1), IL-6 and tumour necrosis factor-α 
(TNF-α) have deleterious effect on the insulin dependent glucose transporter in which 
they decrease the expression and phosphorylation of insulin cell surface receptors 
leading to liver adipocytes and muscle insulin resistance (Aljada et al., 2002). 
Catecholamines have been shown to inhibit insulin binding, tyrosine activity and 
translocation of GLUT-4 (Chiasson et al., 1981). Meanwhile glucocorticoids impair 
insulin mediated glucose uptake by down-regulating various signalling proteins leading 
to impairment of translocation GLUT-4 glucose transporter (Dimitriadis et al., 1997). 
Growth hormone causes insulin resistance through reducing insulin receptors and 
impairing its activation via phosphorylation on tyrosine residues (Smith et al., 1997).  
The insulin resistance is directly proportional to the severity of stress response (Mizock, 
2001).   
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2.2.4 Detrimental effects of hyperglycaemia in the critically ill. 
Hyperglycaemia in critical illness, is not only a marker of severity of illness and 
the predictor of poor outcome, but also has many kinds of adverse effects on vital 
organs (Mizock, 2001). Glucose has been shown to be a powerful pro-inflammatory 
mediator (Dandona et al., 2003) and tight glucose control with insulin below 110 mg/dL 
has proven to confer anti-inflammatory effects in critically ill patients (Hansen et al., 
2003). This pro-inflammatory effect occur both in acutely and chronically 
hyperglycaemia (Esposito et al., 2002). Esposito and co-workers have demonstrated that 
subjects with impaired glucose tolerance had higher baseline TNF-α and IL-6 levels 
compared with their normal controls. Another study has shown that hyperglycaemia 
dose-dependently stimulates TNF-α and IL-6 production in-vitro (Morohoshi et al., 
1996). At the same time, both TNF-α and IL-6 are strongly implicated in the 
development of insulin resistance (Wogensen et al., 1992). Insulin is on the other hand 
has anti-inflammatory effects.  
Another adverse effect of hyperglycaemia is on the innate immune system. 
Hyperglycaemia impairs the ability of the host to combat infection, through several 
mechanisms. Many studies have reported lower chemotaxis of neutrophils in 
hyperglycaemia condition (Delamaire et al., 1997, Mowat and Baum, 1971). One of the 
most informative studies on this matter was done by Wierusz-Wysocka et al. They 
clearly demonstrated a significant reduction in chemotactic migration with increasing 
glucose concentration up to 300 mg/dL in non-diabetic volunteers (Wierusz-Wysocka et 
al., 1988). 
In hyperglycaemic state, for example in poorly controlled diabetes, phagocytosis 
has been considered to be negatively influenced by increased blood glucose level 
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(Turina et al., 2005). In diabetic patients, direct correlation has been observed between 
either blood glucose levels or the glycosylated plasma proteins (HbA1c) and the 
polymorphonuclear cell’s phagocytic capacity (Alexiewicz et al., 1995, Marhoffer et al., 
1992).  
Studies have shown that high blood glucose level inhibits the formation of 
radical oxygen species (ROS) (Dhindsa et al., 2004, Ortmeyer and Mohsenin, 1996, 
Perner et al., 2003). ROS is a group of reactive substances containing an oxygen 
molecule with an unpaired electron like superoxide (O2-) and hydroxyl radical (OH-).  
These toxics neutrophil components are responsible for the disruption of the ingested 
cellular material (Forman and Torres, 2002). Furthermore, study by Ortmeyer and 
Mohsenin when cells were placed back into normoglycemic media, physiologic ROS 
production levels return to normal, confirming the reversible nature of this effect 
(Ortmeyer and Mohsenin, 1996).  
Experiments conducted in peritoneal dialysis groups demonstrated that 
accelerated induction of apoptosis in neutrophils with exposure to glucose-rich media. 
Generally apoptosis provides a delicate balance between the aggressive biological 
behaviour and the safe turnover of potentially harmful immune cells (Turina et al., 
2005).  
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Figure 2: Summary of the pathogenesis and effects of stress hyperglycaemia. Adapted 
from (Farrokhi et al., 2011). 
 
 
2.3 Hyperglycaemia as prognostic factor in patients with critical illness 
Several studies have documented that hyperglycaemia affects outcomes in 
patients with various clinical conditions requiring intensive care, such as myocardial 
infarction, cerebrovascular disorders or traumatic brain injury. The plasma glucose level 
on admission has been shown to be an independent predictor of prognosis after 
myocardial infarction (Stranders et al., 2004, Suleiman et al., 2005). The presence of 
hyperglycaemia following an ischemic and hemorrhagic stroke is associated with a two 
to threefold increased mortality and significant impairment in functional recovery 
(Capes et al., 2001).  
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2.3.1 Hyperglycaemia in myocardial infarction  
Stranders et al (2004), documented that an increase of 18 mg/dL (1 mmol/L) in 
admission blood glucose level in previously non-diabetic subjects post-myocardial 
infarction was associated with an increase in mortality risk of 3% in univarate analysis 
and 4% in adjusted analysis (Stranders et al., 2004). This was 6% and 5% respectively 
in diabetic patients. They also reported long term prognosis for previously non-diabetic 
patients with admission blood glucose of more than 200mg/dL (11.0 mmol/L) 
significantly worse than patients with lesser blood glucose level. This was comparable 
to that of patients with previously known diabetes. Mortality rates in previously non-
diabetic patients and diabetic patients with such blood glucose level were 42.6% and 
43.1% respectively.  
Another study by Suleiman et al (2004) on glucose level in non-diabetic patients 
with acute myocardial infarction, concluded that both fasting and admission glucose 
levels have relation with 30-day mortality with fasting glucose (FG) is superior to 
admission glucose (AG) in the assessment of short term risk (Suleiman et al., 2005). 
Compared with patients with normal FG and AG, the adjusted ORs for 30-days 
mortality were 0.71 in patients with elevated AG and normal FG (95% CI, 0.15 to 3.4; 
P= 0.67), 3.4 for patients with normal AG and elevated FG (95% CI, 1.1 to 10.4; P= 
0.03), and 9.6 for patients with both elevated FG and AG (95% CL, 3.5 to 26.0; P < 
0.0001). 
 
2.3.2 Hyperglycaemia in stroke 
The association between blood glucose level and stroke has been summarised by 
Capes et al (2000) in their meta-analysis study. After stroke of either subtype ischemic 
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or hemorrhagic, the unadjusted relative risk of in-hospital or 30-day mortality 
associated with admission glucose level > 6 to 8 mmol/L (108 to 144 mg/dL) was 3.07 
(95% CI, 2.50 to 3.79) in non-diabetic patients and 1.30 (95% CI, 0.49 to 3.43) in 
diabetic patients (Capes et al., 2000). After ischemic stroke, admission glucose level > 
6.1 to 7.0 mmol/L (110 to 126 mg/dL) was associated with increased risk of in-hospital 
or 30-day mortality in non-diabetic patients only (relative risk= 3.28; 95% CI, 2.32 to 
4.64). After hemorrhagic stroke, admission hyperglycaemia was not associated with 
higher mortality in either diabetic or non-diabetic patients. Non-diabetic stroke 
survivors whose admission glucose level was >6.7 to 8 mmol/L (121 to 144 mg/dL) also 
had a greater risk of poor functional recovery (relative risk 1.41; 95% CI, 1.16 to 1.73). 
 
2.3.3 Hyperglycaemia in trauma 
Hyperglycaemia is also noted after injury in both diabetes and non-diabetes, and 
the severity of injury seems to correlate with the level of hyperglycaemia. Study by 
Laird et al (2004) shows that blood glucose level > 200mg/dL is associated with 
significantly higher infection and mortality rate in severely injured patients independent 
of injury characteristics ( Laird et al., 2004).  
Other study by Yendamuri et al (2003) documented that the hyperglycaemia 
independently predicts increased intensive care unit and hospital length of stay and 
mortality in the trauma population even at lower level of hyperglycaemia (Yendamuri et 
al., 2003). Similar with the previous studies they also confirmed the association of 
hyperglycaemia with infection morbidity. Patients with mild hyperglycaemia (> 
135mg/dL or > 7.5 mmol/L) had increased mortality rate compared with patients with 
normal admission glucose concentrations (15.5% vs. 2.0%, p < 0.01); while patients 
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with moderate hyperglycaemia ( > 200mg/dL or > 11.1 mmol/L) had even greater 
mortality rate compared with corresponding normoglycaemic patients (34.1% vs. 3.7%, 
p < 0.01).  
 
2.3.4 Hyperglycaemia in burn 
The effects of hyperglycaemia in severely burn patients shown a significant 
correlation with greater incidence of positive blood culture and less percentage of skin-
graft taken in the hyperglycaemic patients compared with the normoglycaemic group 
(Gore et al., 2001).  Higher percentage of mortality in the hyperglycaemic group was 
also observed (27% vs. 4%, p< 0.05). 
 
2.3.5 Hyperglycaemia in general illness 
Meanwhile for a more heterogeneous population, stress hyperglycaemia is also 
associated with increased mortality, prolonged hospital stay and higher rate of 
admission to ICU in patients that were admitted to general wards (Umpierrez et al., 
2002). In this particular study patients with new hyperglycaemia had 16% mortality 
compared to patients with history of diabetes mellitus (3%) and normoglycaemia (1.7%; 
both p-value < 0.01). Meanwhile for ICU admission new hyperglycaemia had 29% 
admission compared with known diabetes 14% and normoglyceamia 9% (p-value < 
0.001 vs. known diabetes and < 0.01 vs. normoglyceamia). New hyperglycaemia had 
mean of 9.0 + 0.7 days stay in hospital, known diabetes had 5.5+0.2 days and 
normoglycaemia 4.5+0.1 (both p-value < 0.001).  
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2.4 Hyperglycaemia in sepsis  
Hyperglycaemia has also been indicated to have deleterious effects on patients 
with sepsis. Compare with other critical illness, not much data available regarding 
prevalence of hyperglycaemia in sepsis and their association in mortality or prognostic 
value in patient outcome. A study in Thailand by Rattanaweeboon et al. (2009) has 
shown that stress hyperglycaemia in non-diabetic patients with sepsis was high, (n=70, 
42.3%). In this study, stress hyperglycaemia was defined as fasting plasma glucose of 
more than 100mg /dL (5.5 mmol/L) or random plasma glucose level of more than 140 
mg/dL (7.8 mmol/L) (Rattanataweeboon et al., 2009). They concluded that even though 
the prevalence of stress hyperglycaemia among septic patient is high, they did not find 
significant association between stress hyperglycaemia and mortality outcome.  
The authors of the study attributed the small sample size and less severe 
hyperglycaemic cut-off value for their non significant correlation of hyperglycaemia 
and mortality outcome findings. Their sample of patients included all sepsis patients and 
only half of them were severe sepsis or septic shock patient. This also may affect their 
outcome as the degree of hyperglycaemia may be a marker of more severe illness (Egi 
et al., 2008, Laird et al., 2004, Stranders et al., 2004).  
A study by Leonidou et al, reported that stress hyperglycaemia had higher 
percentages of mortality in severe sepsis compared with patients with normal glucose 
levels (42.5% vs. 13.7%) and known diabetes patients (42.5% vs. 24.6%). They also 
demonstrated that the non-survivors among the stress hyperglycaemia group had 
significantly higher level of fasting blood glucose (182.4 mg/dL vs. 141.3 mg/dL, p-
value < 0.05) and glucose at admission (224.0 mg/dL vs. 181.4 mg/dL, p-value < 0.05) 
than the survivors. No significant differences in blood glucose levels were found 
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between the survivor and non-survivor in the normal glycaemia and diabetes mellitus 
groups.  Even though they concluded that hyperglycaemia is a common finding in 
severe sepsis (42.2%), they were unable to clearly demonstrate whether hyperglycaemia 
itself is a cause of increased mortality or just a marker of increased risk of mortality 
(Leonidou et al., 2008).  
On the other hand among paediatrics septic shock patients, there was correlation 
between blood sugar level and mortality rate. Study by Branco et al. (2005) found that 
in non-survivors, the peak glucose level was 262 ± 110 mg/dL, which was higher (p < 
.01) than that found in survivors (167.8 ± 55 mg/dL). The best peak glucose level for 
predicting death in children with sepsis was 178 mg/dL (sensitivity, 0.714; specificity, 
0.724), and the relative risk of death in patients with peak glucose levels of ≥178 mg/dL 
was 2.59 (range, 1.37-4.88) (Branco et al., 2005). 
Studies have confirmed the prognostic value of blood glucose level in many 
critical illnesses such as trauma, stroke and myocardial infarction, but in sepsis this is 
not entirely explored and investigated. Hence this current study aimed to determine the 
correlation between blood sugar level in predicting the outcome of severe sepsis and 
septic shock patients, and subsequently to seek whether blood sugar level can be a 
reliable prognostic tool in determining the outcome of such patients in emergency 
department.  
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3.0  RESEARCH HYPOTHESIS AND OBJECTIVES 
 
3.1 Research hypothesis 
Hyperglycemia has a predictive outcome of mortality and morbidity in severe sepsis 
and septic shock patients in Emergency Department 
3.2 General research objective 
To investigate whether, hyperglycemia detected during patient initial presentation to 
Emergency Department has a prognostic value in the outcome of severe sepsis and 
septic shock patients. 
3.3 Specific research objective 
1. To determine the prevalence of hyperglycemia in severe sepsis and septic shock 
patients presented to Emergency Department. 
2. To study the demographic characteristics of severe sepsis and septic shock 
patients presented to Emergency Department. 
3. To determine the association between hyperglycemia detected during the initial 
blood glucose measurement and the outcome of severe sepsis and septic shock 
patients in Emergency Department in term of mortality and length of hospital 
stay. 
4. To compare hyperglycemia during initial blood glucose with other prognostic 
variables in predicting the outcome of severe sepsis and septic shock patients.  
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4.0 OPERATIONAL DEFINITION 
1. Infective state:  
Patient presents to ED with complain of infection symptoms in any 
form. Vital sign at triage such as temperature, blood pressure, pulse rate 
or SpO2 were used to screen patients for recruitment.   
2. Triage:  
A process for sorting injured people into groups based on their need for 
or likely benefit from immediate medical treatment. Triage is used on 
the battlefield, at disaster sites, and in hospital emergency rooms when 
limited medical resources must be allocated. Malaysia triage system is a 
three-tier system where the cases are categorized by acuity. The three zones are 
red, yellow and green. 
 
Malaysia Triage Category: 
Triage 
category 
Response  Description of category 
Red zone 
(critical cases) 
Assessment and 
treatment 
immediately ( 
assessment and 
treatment often 
simultaneous) 
Condition that are threats to life or imminent risk 
of deterioration and require immediate aggressive 
intervention   
OR 
The patient’s condition is serious enough or 
deteriorating is rapidly that there is the potential 
of threat to life, or organ system failure if not 
treated within 15 minutes of arrival 
OR 
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The potential for time critical treatment (e.g. 
thrombolysis, antidote) to make a significant 
effect on clinical outcome depends on treatment 
commencing within a few minutes of the patient’s 
arrival in the ED 
Yellow zone 
(semi- critical 
cases) 
Assessment and 
treatment start within 
30 minutes 
The patient’s condition may progress to life or 
limb threatening, or may lead to significant 
morbidity, if assessment and treatment are not 
commenced within 30 minutes of arrival 
OR 
There is potential for adverse outcome if time 
critical treatment is not commenced with 30 
minutes 
OR 
Humane practice mandates the relief of severe 
discomfort or distress 
Green zone 
(non-critical 
cases) 
Assessment and 
treatment start within 
90 minutes 
The patient’s condition may deteriorates, or 
adverse outcome may results, if assessment and 
treatment is not commenced with 1 hour of arrival 
in ED. Symptoms moderate or problem 
OR 
There is potential for adverse outcome if time-
critical treatment is not commenced within hour 
OR 
Likely to require complex work up and 
consultation and/or in-patient management  
OR 
